News items related to: Belarus
-
Russian Federation’s updated patent law puts public health first
The Russian Federation parliament voted this week (13 April 2021) to enshrine into the law the country’s right to enact...
-
Belarus: Civil society pushes for compulsory license as dolutegravir remains overpriced
Positive Movement (PMPlus) in Belarus, one of our partner organizations, is an NGO representing people living with HIV, advocating for...
-
Letter to ViiV Healthcare: No more time to waste – increase access to dolutegravir in Eastern Europe and Central Asia
Dolutegravir is an essential drug in HIV treatment, recommended by the World Health Organization (WHO). Despite the drug being approved...
-
Activists urge Eurasian states to order more affordable medicines, after HIV patent is dropped
AbbVie has waived its patent rights for HIV drug, lopinavir/ritonavir (LPV/r), in many parts of the world, including for the...
